Biolevate
PrivateLast Round
Series A
Sep 22, 2026
Total Funding Raised
$40.73M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Biolevate is a health-tech company that provides an AI-native knowledge platform designed to accelerate scientific discovery and streamline research and regulatory workflows for life sciences professionals.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Document Management, Compliance, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolevate Comparables
Compare Biolevate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorcero | 85% | |
| AlphaLife Sciences | 84% | |
| Narrativa | 84% |
Biolevate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2026 | ||||
| Seed | Nov 26, 2024 |
Key People
Founding team and executive leadership
Biolevate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Global Health Innovation Fund | Series A |
| Orange Ventures | Series A |
| EQT Ventures | Series A, Seed |
| Bpifrance | Seed |
| Groupe RAISE | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
$34M round led by Groupe RAISE and Orange.
- Aug 21, 2026
Monthly visitors increased 163% MoM, reaching 4.3K.
Biolevate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biolevate's valuation, stock price, and market status.
Is Biolevate a public or private company?
Biolevate is a private company.
What is the current stock price of Biolevate?
Biolevate is a private company, so its shares have no public market price. Caplight tracks Biolevate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biolevate worth (valuation)?
Valuation information for Biolevate is not publicly available.
Can I buy Biolevate stock?
Biolevate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biolevate's last funding round?
Biolevate's most recent funding round was Series A on September 22, 2026.
Who are the main investors in Biolevate?
Key investors in Biolevate include Orange Ventures, EQT Ventures, Groupe RAISE.
Will Biolevate IPO soon?
No public IPO plans have been announced for Biolevate.
How can I track Biolevate secondary market activity?
Caplight tracks bids, offers, and trades in Biolevate's shares on secondary markets.